Original price was: $645.00.Current price is: $65.00.

Harvard Diabetes Comorbidities and Complications 2023 (Videos)

Optimizing Diabetes Care: A Comprehensive Online CME Program

This online Continuing Medical Education (CME) program is designed to provide healthcare professionals with the latest updates and best practices in managing diabetes and related conditions. Leveraging live streaming, electronic Q&A, and remote learning technologies, this comprehensive course aims to enhance patient care and outcomes.

Course Overview

This four-day online CME program covers a wide range of topics, including obesity management, cardiovascular disease, heart failure, coronary artery disease, hypertension, hyperglycemia, hypoglycemia, dyslipidemia, non-alcoholic fatty liver disease, peripheral vascular disease, chronic kidney disease, and sexual dysfunction in patients with diabetes.

Day 1: Obesity Management and Cardiovascular Health

Monday, July 31, 2023

  • Welcome and Introduction: A. Enrique Caballero, MD, and Romela Petrosyan, MD
  • Obesity Management: Medical Treatment of Obesity, Updates, and Best Practices for Individualizing Therapies – Bartolome Burguera, MD
  • Advances in Surgical Treatment of Obesity and Why and When to Refer Patients with Diabetes – Philip Schauer, MD
  • Concurrent Breakout Sessions:
    • CARDIOVASCULAR – Diagnosis and Management of Heart Failure in the Patient with Diabetes: What Every Physician Now Needs to Know – Akshay Desai, MD
    • METABOLIC – Updates in Continuous Glucose Monitoring and Insulin Pumps in Diabetes Management – Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
  • Wrap-up of Day 1: Course Directors

Day 2: Diabetes Complications and Management

Tuesday, August 1, 2023

  • Welcome and Introduction to Day 2 Activities: A. Enrique Caballero, MD, and Romela Petrosyan, MD
  • UPDATES in DIABETES MANAGEMENT: Adjusting Pharmacological Therapies in the Patient with Diabetes Complications – Marie McDonnell, MD
  • Updates in the Prevention and Management of Hypoglycemia – Devin Steenkamp, MD
  • Concurrent Breakout Sessions:
    • CARDIOVASCULAR – Diagnosis and Management of Coronary Artery Disease in the Patient with Diabetes: Practical Tools for the Busy Clinician – Christopher Cannon, MD
    • METABOLIC – Weight Variability and Diabetes Complications – Antonio Ceriello, MD
  • Wrap-up of Day 2: Course Directors

Day 3: Cardiovascular and Renal Risk Reduction

Wednesday, August 2, 2023

  • Welcome and Introduction to Day 3 Activities: A. Enrique Caballero, MD, and Romela Petrosyan, MD
  • UPDATES for CARDIOVASCULAR and RENAL RISK REDUCTION in the PATIENT with DIABETES: Practical Recommendations for the Use of GLP-1 RA in Clinical Practice and Their Impact on CV and Renal Risk Reduction – Vanita Aroda, MD
  • KEYNOTE: The Expanded Role of SGLT-2 Inhibitors in Diabetes, Cardiovascular, and Renal Disease: Implications for Clinical Practice – Deepak Bhatt, MD
  • KEYNOTE: The Role of MRA Antagonists in CV and Renal Risk Reduction in the Patient with Diabetes: Recent Data and Practical Implications – George Bakris, MD
  • Concurrent Breakout Sessions:
    • CARDIOVASCULAR – Updates in the Evaluation and Management of Peripheral Vascular Disease in the Patient with Diabetes – Allen D. Hamdan, MD
    • METABOLIC – Diabetes in Pregnancy: New Diagnosis and Treatment Guidelines – Florence Brown, MD
  • The Edward S. Horton Lecture: Management of Diabetes and Related Disorders in Diverse Racial/Ethnic Populations – A. Enrique Caballero, MD
  • Wrap-up of Day 3: Course Directors

Day 4: Chronic Kidney Disease and Diabetes

Thursday, August 3, 2023

  • Welcome and Introduction to Day 4 Activities: A. Enrique Caballero, MD, and Romela Petrosyan, MD
  • CHRONIC KIDNEY DISEASE in the PATIENT with DIABETES: Evaluation and Monitoring of Diabetic CKD – Romela Petrosyan, MD
  • KEYNOTE: Current Clinical Guidelines for the Management of CKD in Diabetes – Katherine R. Tuttle, MD, FASN, FACP, FNKF
  • Concurrent Breakout Sessions:
    • CARDIOVASCULAR – Evaluation and Management of Sexual Dysfunction in Patients with Diabetes – Martin N. Kathrins, MD
    • METABOLIC – Updates and Best Practices for State-of-the-Art Insulin Therapy – Guillermo Umpierrez, MD
  • ADVANCES in NON-ALCOHOLIC FATTY LIVER DISEASE: Diagnosis and Management of Non-Alcoholic Fatty Liver Disease – Ken Cusi, MD
  • Closing Remarks: Course Directors

All concurrent breakout sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.

Additional information

Author